Health and Fitness Health and Fitness
Wed, November 3, 2010
[ Wed, Nov 03rd 2010 ] - Market Wire
Illumina Introduces TruSeqa" Sample Prep and Exome Enrichment Kits
[ Wed, Nov 03rd 2010 ] - Market Wire
Emergent BioSolutions Receives Loan Repayment from Protein Sciences Corporation
[ Wed, Nov 03rd 2010 ] - Market Wire
CardioNet, Inc. Announces National Reimbursement Rate for Mobile Cardiovascular Telemetry
[ Wed, Nov 03rd 2010 ] - Market Wire
Orthovita Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance
[ Wed, Nov 03rd 2010 ] - Market Wire
BioCryst Awarded $1.1 Million in Grants for Qualifying Therapeutic Development Projects
[ Wed, Nov 03rd 2010 ] - Market Wire
Cardiovascular Systems Settles Employment Litigation
[ Wed, Nov 03rd 2010 ] - Market Wire
Curis Awarded $500,000 in Grants Under the Patient Protection and Affordable Care Act
[ Wed, Nov 03rd 2010 ] - Market Wire
TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q3 2010
Tue, November 2, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
Teva Reports Record Third Quarter 2010 Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Insight Imaging Reports Discussions on Potential Restructuring Plan
[ Tue, Nov 02nd 2010 ] - Market Wire
Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2011 on November 8, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
[ Tue, Nov 02nd 2010 ] - Market Wire
SurModics to Webcast Fourth Quarter and Fiscal Year 2010 Earnings Conference Call November 10
[ Tue, Nov 02nd 2010 ] - Market Wire
Corgenix to Host Conference Call to Discuss First Quarter Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Notice of Medical Facilities Corporation';s Fisca .. 0 Third Quarter Financial Results Conference Call
[ Tue, Nov 02nd 2010 ] - Market Wire
WellCare Board Adopts Majority Voting Standard for Director Elections
[ Tue, Nov 02nd 2010 ] - Market Wire
Aeolus Pharmaceuticalsa? AEOL 10150 Promotes Surv .. man Primates Exposed to Lethal Doses of Radiation
[ Tue, Nov 02nd 2010 ] - Market Wire
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Qua .. er 2010 Financial Results Call Set for November 9
[ Tue, Nov 02nd 2010 ] - Market Wire
Tolerx Forms Scientific Advisory Board to Advance Research in Type 1 Diabetes
[ Tue, Nov 02nd 2010 ] - Market Wire
Coventry Health Care, Expeditors International, A .. source Bergen, Principal Financial and Kellogga?s
[ Tue, Nov 02nd 2010 ] - Market Wire
Neurocrine Biosciences, Jacobs Engineering, Ford, Kellogg and Honda Motor Co.
[ Tue, Nov 02nd 2010 ] - Market Wire
DUSA Pharmaceuticals, Inc.® to Host Third Quarte .. Highlights and Financial Results Conference Call
Mon, November 1, 2010
[ Mon, Nov 01st 2010 ] - Market Wire
Prestige Brands Holdings, Inc. Completes Purchase of Blacksmith Brands
[ Mon, Nov 01st 2010 ] - Market Wire
Biomagnetics Completes Audit and Financial Review
[ Mon, Nov 01st 2010 ] - Market Wire
NeoStem to Present at Cell Therapy Industry Summi .. eld on November 3-5, 2010 in Carlsbad, California
[ Mon, Nov 01st 2010 ] - Market Wire
Clinical Data, Inc. Granted Orphan Drug Designati .. for PRX-8066 for Pulmonary Arterial Hypertension
[ Mon, Nov 01st 2010 ] - Market Wire
Health Management Associates, Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference
[ Mon, Nov 01st 2010 ] - Market Wire
Two Directors Step Down from Elan Board in Accordance with Previously Announced Intention
[ Mon, Nov 01st 2010 ] - Market Wire
I composti sperimentali per l'epatite C di Gilead .. azione con terapie standard di cura ottengono una
[ Mon, Nov 01st 2010 ] - Market Wire
Theragenics to Report Third Quarter 2010 Financial Results Tuesday, November 9
[ Mon, Nov 01st 2010 ] - Market Wire
Orthovita to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Mon, Nov 01st 2010 ] - Market Wire
ARIAD to Webcast Conference Call on Third Quarter 2010 Financial Results
[ Mon, Nov 01st 2010 ] - Market Wire
Hepatitis-C-Prfprparate GS 9190 und GS 9256 von G .. Phase II zusammen mit Standardtherapien wesentli
[ Mon, Nov 01st 2010 ] - Market Wire
American Anesthesiology Announces the Acquisition of Greensboro, NC, Group Practice
[ Mon, Nov 01st 2010 ] - Market Wire
Medisafe 1 Technologies Appoints Tali Skoczylas as Chair of Medical Advisory Board
[ Mon, Nov 01st 2010 ] - Market Wire
Porex Corporation Divests Surgical Division to Stryker Corporation
Sat, October 30, 2010
[ Sat, Oct 30th 2010 ] - Market Wire
A Celgene anuncia resultados financeiros e operacionais recordes no terceiro trimestre de 2010
[ Sat, Oct 30th 2010 ] - Market Wire
Viread® for Hepatitis B Maintains Antiviral Supp .. ent of Resistance Through Four Years of Treatment
[ Sat, Oct 30th 2010 ] - Market Wire
Gileada?s Investigational Hepatitis C Compounds G .. tion with Standard of Care Therapies Achieve Subs
[ Sat, Oct 30th 2010 ] - Market Wire
Salix Pharmaceuticals Previews Data Slated for Pr .. ting of the American Association for the Study of
[ Sat, Oct 30th 2010 ] - Market Wire
New Data From Phase 3 Studies Showed Superior SVR .. with Telaprevir-Based Combination Therapy in Peop
Fri, October 29, 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Fitch Affirms Boston Scientific's IDR at 'BB+'; Outlook to Positive
[ Fri, Oct 29th 2010 ] - Market Wire
Teva Invites Public to Listen to Its Respiratory Opportunity Meeting Webcast
[ Fri, Oct 29th 2010 ] - Market Wire
Ligand to Report Third Quarter Results on November 9
[ Fri, Oct 29th 2010 ] - Market Wire
St. Jude Medical???2010??????????????
[ Fri, Oct 29th 2010 ] - Market Wire
Celgene meldet rekordverdchtiges Betriebs- und Finanzergebnis fr das dritte Quartal 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Seattle Genetics to Present at Oppenheimer Healthcare Conference
[ Fri, Oct 29th 2010 ] - Market Wire
Idera Pharmaceuticals Appoints Sudhir Agrawal as .. Directors and William S. Reardon as Lead Director
[ Fri, Oct 29th 2010 ] - Market Wire
Alnylam Scientists to Present New Data on RNAi Th .. Meeting of the American Association for the Stud
[ Fri, Oct 29th 2010 ] - Market Wire
MannKind Corporation Reports 2010 Third Quarter Financial Results
[ Fri, Oct 29th 2010 ] - Market Wire
Abstracts Highlighting Data from Enzona?s mRNA An .. d for Presentation at 2010 EORTC-NCI-AACR Meeting
[ Fri, Oct 29th 2010 ] - Market Wire
Celgene Corporation to Present at Oppenheimera?s 21st Annual Healthcare Conference
[ Fri, Oct 29th 2010 ] - Market Wire
Compugen Licenses Novel Oncology Target to Seattle Genetics
[ Fri, Oct 29th 2010 ] - Market Wire
Magellan Health Services Reports Third Quarter 2010 Financial Results
[ Fri, Oct 29th 2010 ] - Market Wire
Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
Thu, October 28, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
AGA Medical to Report Third Quarter Earnings on Monday, November 8, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Urologix to Host Its Fiscal 2011 First Quarter Conference Call
[ Thu, Oct 28th 2010 ] - Market Wire
Exact Sciences Reports Positive Results for Colorectal Cancer Screening Test
[ Thu, Oct 28th 2010 ] - Market Wire
Health Net Expands Mobile Capabilities
[ Thu, Oct 28th 2010 ] - Market Wire
Emeritus Corporation to Host Third Quarter 2010 Earnings Conference Call and Webcast
[ Thu, Oct 28th 2010 ] - Market Wire
ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
[ Thu, Oct 28th 2010 ] - Market Wire
Celgene Reports Record Third Quarter 2010 Operating and Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
Celgene comunica risultati finanziari e operativi record per il terzo trimestre del 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Natus Medical Announces 2010 Third Quarter Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
Curis Reports Third Quarter 2010 Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
Pro-Pharmaceuticals Ships First Commercial Order for DAVANAT®
[ Thu, Oct 28th 2010 ] - Market Wire
ACADIA Pharmaceuticals Enters Agreement with Biov .. and Regain North American Rights to Pimavanserin
[ Thu, Oct 28th 2010 ] - Market Wire
BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update
[ Thu, Oct 28th 2010 ] - Market Wire
AngioDynamics Announces Election of Kevin J. Gould to Board of Directors
Wed, October 27, 2010
[ Wed, Oct 27th 2010 ] - Market Wire
Crown Oil and Gas Announces Appointment of Director
[ Wed, Oct 27th 2010 ] - Market Wire
Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
Northstar Healthcare Announces Senior Management Changes
[ Wed, Oct 27th 2010 ] - Market Wire
Neue therapeutische Oberflche von KCI verbessert .. tegritt fr Prvention und Management von Dekubitus
[ Wed, Oct 27th 2010 ] - Market Wire
Nuova superficie terapeutica sviluppata da KCI ri .. la prevenzione e la gestione delle piaghe da dec
[ Wed, Oct 27th 2010 ] - Market Wire
ZIOPHARM Oncology to Present at Oppenheimer 21st Annual Healthcare Conference
[ Wed, Oct 27th 2010 ] - Market Wire
Bond Labsa? Resurrectiona" Conducts In-Store Promotions for Cub Foods®
[ Wed, Oct 27th 2010 ] - Market Wire
Successful IsoRay Study of Cesium-131 Internal Ra .. Breast CancerPaves the Way for Advanced Treatment
[ Wed, Oct 27th 2010 ] - Market Wire
Exact Sciences Reports Third-Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
St. Jude Medical to Showcase Portfolio of Products at Asia-Pacific Heart Rhythm 2010
[ Wed, Oct 27th 2010 ] - Market Wire
Salix Pharmaceuticals Launches Corporate Twitter Account and Facebook Page
[ Wed, Oct 27th 2010 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES THE NOMINATION OF ADDITIONAL MEMBERS TO THE BOARD OF DIRECTORS
[ Wed, Oct 27th 2010 ] - Market Wire
BioCrysta?s Partner Shionogi Receives Approval for Pediatric Use Of Peramivir in Japan
[ Wed, Oct 27th 2010 ] - Market Wire
Santarus to Hold Third Quarter 2010 Financial Results Conference Call on November 8
Tue, October 26, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
IPC The Hospitalist Company CEO Dr. Adam Singer Named MGMA-ACMPE Physician Executive of the Year
[ Tue, Oct 26th 2010 ] - Market Wire
Capsalus Corp. Invests in Nationally-Recognized aSocial Helpinga Network
[ Tue, Oct 26th 2010 ] - Market Wire
ARIAD Announces Pricing of Public Offering of Common Stock
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and Bend Research Enter into Collaboration to .. ion Development and Analytical Testing Capabiliti
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and VirtualScopics Establish Strategic Alliance for Medical Imaging Services
[ Tue, Oct 26th 2010 ] - Market Wire
Obagi Medical Products Announces Proposed Seconda .. ockholders and Authorization to Repurchase Shares
[ Tue, Oct 26th 2010 ] - Market Wire
Oncolytics Biotech® Inc. Collaborators Prese .. al Colorectal Cancer Study at the International S
[ Tue, Oct 26th 2010 ] - Market Wire
Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call
[ Tue, Oct 26th 2010 ] - Market Wire
Biogen Idec Reports Third Quarter 2010 Results
[ Tue, Oct 26th 2010 ] - Market Wire
Amedisys Reports Third Quarter Revenue and Earnings, Updates 2010 Guidance
[ Tue, Oct 26th 2010 ] - Market Wire
Compugen Reports Third Quarter 2010 Financial Results
[ Tue, Oct 26th 2010 ] - Market Wire
Synergetics USA Announces New Products and Record .. rican Academy of Ophthalmology 2010 Annual Meetin
[ Tue, Oct 26th 2010 ] - Market Wire
Cascade Technologies Corporation Announces Appointment of Robert Chave as Chief Technologist
[ Tue, Oct 26th 2010 ] - Market Wire
ICON Announces Appointment of Cathrin Petty to Board of Directors
Mon, October 25, 2010
[ Mon, Oct 25th 2010 ] - Market Wire
Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2
[ Mon, Oct 25th 2010 ] - Market Wire
Quest PharmaTech Announces Treasury Issue of Common Shares
[ Mon, Oct 25th 2010 ] - Market Wire
Synovis Life Technologies to Present at the Singu .. l Best of the Uncovereds Conference on November 4
[ Mon, Oct 25th 2010 ] - Market Wire
Abiomed Second Quarter Fiscal 2011 Earnings and Conference Call Notification
[ Mon, Oct 25th 2010 ] - Market Wire
Helicos BioSciences Amends Patent Infringement La .. ciences to Include Illumina and Life Technologies
[ Mon, Oct 25th 2010 ] - Market Wire
Emeritus to Acquire Rehab Therapy Services Group
[ Mon, Oct 25th 2010 ] - Market Wire
Seattle Genetics and Millennium to Highlight Bren .. t the International Symposium on Hodgkin Lymphoma
[ Mon, Oct 25th 2010 ] - Market Wire
BioCryst to Present at Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Bestuur Alcon kiest nieuwe voorzitter
[ Mon, Oct 25th 2010 ] - Market Wire
AngioDynamics to Participate at the 21st Annual Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Il Consiglio di amministrazione di Alcon nomina il suo nuovo Presidente
[ Mon, Oct 25th 2010 ] - Market Wire
Junta de Alcon elige nuevo presidente
[ Mon, Oct 25th 2010 ] - Market Wire
Alcon-Verwaltungsrat whlt neuen Vorsitzenden
[ Mon, Oct 25th 2010 ] - Market Wire
Conselho da Alcon elege novo presidente
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ] - Market Wire
Gileada?s Cayston® superieur aan Tobramycine inh .. anden durende head-to-head cystic fibrosis studie
[ Sun, Oct 24th 2010 ] - Market Wire
Alcon Board Elects New Chairman
[ Sun, Oct 24th 2010 ] - Market Wire
HERBALIFE LANZA NUEVOS PRODUCTOS INCLUYENDO BATID .. EINA SIN ALERGENOS Y SUPLEMENTO NUTRICIONAL COQ10
Sat, October 23, 2010
[ Sat, Oct 23rd 2010 ] - Market Wire
Dr. Reddya?s Q2 FY11 Financial Results
Fri, October 22, 2010
[ Fri, Oct 22nd 2010 ] - Market Wire
Cayston® di Gilead si dimostrato superiore alla .. alazione in uno studio di raffronto diretto della
[ Fri, Oct 22nd 2010 ] - Market Wire
Cayston® von Gilead zeigt in sechsmonatiger Kopf .. Fibrose berlegenheit gegenber Tobramycin-Inhalat
[ Fri, Oct 22nd 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of Clarient, Inc. in Connection with the Propo
[ Fri, Oct 22nd 2010 ] - Market Wire
MannKind Corporation to Hold 2010 Third Quarter F .. ncial Results Conference Call on October 29, 2010
[ Fri, Oct 22nd 2010 ] - Market Wire
Sycamore Entertainment Group Launches New Corporate Website
[ Fri, Oct 22nd 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Clarient Inc. a" CLRT
[ Fri, Oct 22nd 2010 ] - Market Wire
Clarient, Inc. Shareholder Investigation by Brisc .. Regarding the Buyout by General Electric Company
[ Fri, Oct 22nd 2010 ] - Market Wire
Cardiac Science Shareholder Investigation by Bris .. ing the Merger with Opto Circuits (India) Limited
[ Fri, Oct 22nd 2010 ] - Market Wire
Kendall Law Group Investigates Clarient, Inc. Acquisition for Shareholders
[ Fri, Oct 22nd 2010 ] - Market Wire
Wright Medical Group, Inc. Announces Full Commerc .. f PRO-STIMa" Osteoinductive Bone Graft Substitute
[ Fri, Oct 22nd 2010 ] - Market Wire
Health Net Federal Services Awarded Department of .. ns Affairs CBO Outpatient Recovery Audit Contract
[ Fri, Oct 22nd 2010 ] - Market Wire
St. Jude Medical Board of Directors Authorizes Share Repurchase
[ Fri, Oct 22nd 2010 ] - Market Wire
Biogen Idec en Genentech melden herstructurering anti-CD20 samenwerkingsovereenkomst
[ Fri, Oct 22nd 2010 ] - Market Wire
Biogen Idec y Genentech anuncian modificacin en su acuerdo de colaboracin de anticuerpos anti-CD20
Thu, October 21, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. ction Lawsuit against Acura Pharmaceuticals, Inc.
[ Thu, Oct 21st 2010 ] - Market Wire
Emergency Medical Services to Host Conference Cal .. sults for Third Quarter Ending September 30, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Merit Medical Systems to Announce Third Quarter Results on November 4, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Apricus Biosciences to Present at the FSX Investor Conference in Phoenix, AZ on October 29, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
IntegraMed® to Participate at Fifth Annual Singu .. h Best of The Uncovereds Conference on November 4
[ Thu, Oct 21st 2010 ] - Market Wire
PerkinElmer to Hold Earnings Call on Thursday, November 4, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Orthovita Announces 2010 Third Quarter Product Sales
[ Thu, Oct 21st 2010 ] - Market Wire
Laboratory Corporation of America® Holdings Announces 2010 Third Quarter Results
[ Thu, Oct 21st 2010 ] - Market Wire
BioCryst to Present New Clinical & Virologic Data .. or I.V. Peramivir at the 48th Annual IDSA Meeting
[ Thu, Oct 21st 2010 ] - Market Wire
ImmunoGen, Inc. Announces Conference Call to Disc .. First Quarter Fiscal Year 2011 Financial Results
[ Thu, Oct 21st 2010 ] - Market Wire
Alexion Reports Third Quarter 2010 Results
[ Thu, Oct 21st 2010 ] - Market Wire
Columbia Laboratories to Discuss Third Quarter 20 .. 0 Financial Results on November 4 Conference Call
[ Thu, Oct 21st 2010 ] - Market Wire
Icon Reports Revenues of $225 Million up 2% on Prior Year (Nasdaq:ICLR) (ISIN:IE0005711209)
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
Vascular Solutions Acquires Snare Product Line from Radius Medical Technologies
[ Wed, Oct 20th 2010 ] - Market Wire
Law Office of Jonathan M. Stein, P.L. Investigate .. y Duty by the Board of AGA Medical Holdings, Inc.
[ Wed, Oct 20th 2010 ] - Market Wire
STJ, AGAM, BAC, MDT, BSX
[ Wed, Oct 20th 2010 ] - Market Wire
Zacks Releases Four Powerful ''Buy'' Stocks: OREX,ABV,THI,CLD
[ Wed, Oct 20th 2010 ] - Market Wire
IntegraMed® Expands Orlando Attain Fertility Cen .. f Veteran Fertility Specialist, Dr. Frank Riggall
[ Wed, Oct 20th 2010 ] - Market Wire
BioCryst Ranked Number Five in Deloittea?s 2010 T .. am for Fastest Growing Companies in North America
[ Wed, Oct 20th 2010 ] - Market Wire
Northstar Healthcare announces Toronto Stock Exch .. review following change of control under private
[ Wed, Oct 20th 2010 ] - Market Wire
St. Jude Medical Reports Third Quarter 2010 Results
[ Wed, Oct 20th 2010 ] - Market Wire
Incyte Achieves $19 Million Milestone as Novel JA .. s into Phase IIb Development for Rheumatoid Arthr
[ Wed, Oct 20th 2010 ] - Market Wire
Medical Action Industries 2nd Quarter Earnings Call to Take Place on November 3, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
Spectranetics to Hold 2010 Third Quarter Financial Results Conference Call on October 27
[ Wed, Oct 20th 2010 ] - Market Wire
Dyax Corp. to Host Third Quarter 2010 Earnings Call and Webcast
[ Wed, Oct 20th 2010 ] - Market Wire
NOTICE OF NUVO RESEARCH 2010 THIRD QUARTER RESULTS CONFERENCE CALL
Tue, October 19, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
Salix Pharmaceuticals Acquires Lumacana" from Photocure
[ Tue, Oct 19th 2010 ] - Market Wire
Capsalus Corp. Announces Ticker Symbol Change to aWELLa
[ Tue, Oct 19th 2010 ] - Market Wire
Orthofix International Announces Promotion of Jef .. humm To Senior Vice President and General Counsel
[ Tue, Oct 19th 2010 ] - Market Wire
Fonds de solidarite FTQ Converting Remainder of its Preferred Shares in Bioniche
[ Tue, Oct 19th 2010 ] - Market Wire
Deciso da corte distrital recebida no processo da patente NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Micromet to Report Third Quarter 2010 Financial Results on November 9
[ Tue, Oct 19th 2010 ] - Market Wire
Gerichtsentscheidung im NPWT-Patentverfahren durch District Court
[ Tue, Oct 19th 2010 ] - Market Wire
Tribunal de distrito emiti decisin en litigio por patentes de NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Besluit arrondissementsrechtbank ontvangen in octrooizaak NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Forest Laboratories, Inc. Reports Second Quarter Fiscal Year 2011 Earnings Per Share of $1.00
[ Tue, Oct 19th 2010 ] - Market Wire
Aeterna Zentaris CEO to Chair Cancer Symposium Se .. Annual Congress of International Drug Discovery S
[ Tue, Oct 19th 2010 ] - Market Wire
Compugen Ltd. to Review Third Quarter 2010 Financial Results on Tuesday, October 26, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
Flamel Technologies Achieves Clinical Milestone w .. xtended Release Formulation of Interferon beta-1a
Mon, October 18, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
U.S. Food and Drug Administration Approves BARACL .. nt for Chronic Hepatitis B Patients with Evidence
[ Mon, Oct 18th 2010 ] - Market Wire
Zynex Increases Board of Directors
[ Mon, Oct 18th 2010 ] - Market Wire
XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and .. stipation Irritable Bowel Syndrome Symptoms: Data
[ Mon, Oct 18th 2010 ] - Market Wire
BioScrip, Inc. to Host 2010 Third Quarter Earnings Call
[ Mon, Oct 18th 2010 ] - Market Wire
Micromet to Present at the 2010 Newsmakers in the Biotechnology Industry Conference
[ Mon, Oct 18th 2010 ] - Market Wire
Gegevens ter verdere ondersteuning van onderzoek .. en gepresenteeerd op het 26ste congress van het E
[ Mon, Oct 18th 2010 ] - Market Wire
GenMark Diagnostics Schedules Third Quarter Earni .. Release and Conference Call for November 4, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
Lannett Company Launches Fluphenazine HCl Tablets USP
[ Mon, Oct 18th 2010 ] - Market Wire
BioSante Pharmaceuticals Reaches Key LibiGel® Safety Study Enrollment Target
[ Mon, Oct 18th 2010 ] - Market Wire
Celgene Corporation to Announce Third Quarter 2010 Results on October 28, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
Presentacin de nuevos datos que apoyan el ensayo .. 26 Congreso del Comit© Europeo para el tratamien
[ Mon, Oct 18th 2010 ] - Market Wire
St. Jude Medical and AGA Medical Announce Definitive Agreement
[ Mon, Oct 18th 2010 ] - Market Wire
BioCryst Pharmaceuticals to Announce Third Quarter 2010 Financial Results on October 28, 2010
Sun, October 17, 2010
[ Sun, Oct 17th 2010 ] - Market Wire
Neue Daten, die einen mglichen Nutzen des JC-Viru .. den auf dem 26. Kongress des European Committee f
Sat, October 16, 2010
[ Sat, Oct 16th 2010 ] - Market Wire
Des donn©es soutenant l'essai clinique sur les a .. ©es lors du 26e Congrs du Comit© europ©en pour
[ Sat, Oct 16th 2010 ] - Market Wire
Celgene voltooit acquisitie van Abraxis
[ Sat, Oct 16th 2010 ] - Market Wire
Presentati dati che confermano ulteriormente anal .. JC in occasione del 26o Congresso del Comitato e
[ Sat, Oct 16th 2010 ] - Market Wire
Dr. Reddya?s announces the approval of Lansoprazole delayed-release capsules
[ Sat, Oct 16th 2010 ] - Market Wire
Early Initiation of Treatment with Copaxone® Pro .. in Delaying Conversion to Clinically Definite MS
Fri, October 15, 2010
[ Fri, Oct 15th 2010 ] - Market Wire
ADDING MULTIMEDIA BOTOX® (onabotulinumtoxinA) FD .. atment Option for Adult Chronic Migraine Sufferer
[ Fri, Oct 15th 2010 ] - Market Wire
DaVita Inc. Announces Results as of Consent Payme .. Supplemental Indentures Related to Its 6 5/8% Sen
[ Fri, Oct 15th 2010 ] - Market Wire
BOTOX® (onabotulinumtoxinA) FDA Approved as Prop .. tment Option for Adult Chronic Migraine Sufferers
[ Fri, Oct 15th 2010 ] - Market Wire
Celgene schliet bernahme von Abraxis ab
[ Fri, Oct 15th 2010 ] - Market Wire
Celgene completa l'acquisizione di Abraxis
[ Fri, Oct 15th 2010 ] - Market Wire
Celgene Conclui Aquisio da Abraxis
[ Fri, Oct 15th 2010 ] - Market Wire
Celgene finalise la?acquisition da?Abraxis
[ Fri, Oct 15th 2010 ] - Market Wire
Celgene Completes Acquisition of Abraxis
[ Fri, Oct 15th 2010 ] - Market Wire
New Data Evaluating Laquinimod for the Treatment .. ple Sclerosis Demonstrate Neuroprotective Effects
[ Fri, Oct 15th 2010 ] - Market Wire
ALGN, FCN, GOOG, SWY, GCI
[ Fri, Oct 15th 2010 ] - Market Wire
se podran ahorrar US$ 3.5 billones durante 25 aos .. dicare y del modelo de arancel por servicio de Me
[ Fri, Oct 15th 2010 ] - Market Wire
Phase II Study with Ocrelizumab Shows Significant .. Disease Activity for Multiple Sclerosis Patients
[ Fri, Oct 15th 2010 ] - Market Wire
Bioniche Scientists Present at Modern Vaccine &; Adjuvant Formulation Conference in France

Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call


//health-fitness.news-articles.net/content/2010/ .. rter-2010-financial-results-conference-call.html
Published in Health and Fitness on Tuesday, October 26th 2010 at 4:46 GMT by Market Wire   Print publication without navigation


SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Exelixis, Inc. (Nasdaq:EXEL) will release its third quarter 2010 financial results on Thursday, November 4, 2010 after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. ET/ 2:00 p.m. PT, in which Exelixis management will discuss the financial results and financial outlook, and will provide a general business update. The webcast may be accessed in the Event Calendar page under Investors at [ http://www.exelixis.com ].

An audio replay of the webcast will be available until 11:59 p.m ET/ 8:59 p.m. PT on December 4, 2010. Access numbers for the replay are: 1-888-286-8010 (domestic) and 1-617-801-6888 (international), and the passcode is 94605525.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its biological expertise and integrated research and development capabilities to generate a pipeline of development compounds with significant therapeutic and commercial potential for the treatment of cancer and potentially other serious diseases. Currently, Exelixisa™ broad product pipeline includes investigational compounds in phase 3, phase 2, and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, GlaxoSmithKline, Genentech (a wholly owned member of the Roche Group), Boehringer Ingelheim, and Daiichi-Sankyo. For more information, please visit the companya™s web site at [ http://www.exelixis.com ].

Exelixis and the Exelixis logo are registered U.S. trademarks.


Publication Contributing Sources